AutoSynVax vaccineAlternative Names: AutoSynVax™
Latest Information Update: 15 Feb 2017
At a glance
- Originator PhosImmune; Pure MHC
- Developer Agenus
- Class Cancer vaccines; Heat shock proteins; Monoclonal antibodies; Peptide vaccines; Peptides; Synthetic vaccines
- Mechanism of Action Apoptosis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Cancer
Most Recent Events
- 01 Jan 2017 Phase-I clinical trials in Cancer in USA (SC) (NCT02992977)